Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes Journal Article


Authors: Houghton, C. S. B.; Engelhorn, M. E.; Liu, C.; Song, D.; Gregor, P.; Livingston, P. O.; Orlandi, F.; Wolchok, J. D.; McCracken, J.; Houghton, A. N.; Guevara-PatiƱo, J. A.
Article Title: Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes
Abstract: One strategy to generate T-cell responses to tumors is to alter subdominant epitopes through substitution of amino acids that are optimal anchors for specific MHC molecules, termed heteroclitic epitopes. This approach is manually error-prone and time-consuming. In here, we describe a computer-based algorithm (EpitOptimizer) for the streamlined design of heteroclitic epitopes. Analysis of two cancer-related proteins showed that EpitOptimizer-generated peptides have enhanced MHC-I binding compared with their wild-type counterparts; and were able to induce stronger CD8+ T-cell responses against their native epitope. These data demonstrate that this approach can serve as the basis of epitope-engineering against cancer and intracellular pathogens.
Keywords: controlled study; unclassified drug; nonhuman; validation process; neoplasms; t cells; cd8+ t lymphocyte; cd8-positive t-lymphocytes; animal cell; mouse; animals; mice; computational biology; animal experiment; drug design; algorithms; wild type; mice, inbred c57bl; mice, transgenic; models, animal; amino acid sequence; molecular sequence data; cancer vaccines; algorithm; cancer immunization; vaccination; epitope; tumor protein; histocompatibility antigens class i; peptides; tumor immunity; immunological adjuvant; mutagenesis, site-directed; computer program; major histocompatibility antigen class 1; plasmid dna; peptide derivative; epitopes; cross reactions; protein engineering; antigens/peptides/epitopes; titermax
Journal Title: Vaccine
Volume: 25
Issue: 29
ISSN: 0264-410X
Publisher: Elsevier Inc.  
Date Published: 2007-07-20
Start Page: 5330
End Page: 5342
Language: English
DOI: 10.1016/j.vaccine.2007.05.008
PUBMED: 17570567
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 11" - "Export Date: 17 November 2011" - "CODEN: VACCD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Polly Gregor
    29 Gregor
  2. Jedd D Wolchok
    905 Wolchok
  3. Cailian Liu
    60 Liu
  4. Alan N Houghton
    364 Houghton
  5. Da Song
    2 Song